Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03043261 · ClinicalTrials.gov registry record · NA

Effective Management of Emotional Response to Generate Well-Being Post-HF Exacerbation

A NA study of Congestive Heart Failure, sponsored by Duke University.

Completed
Registry status
NA
Development phase
3
Enrollment target
1
Study location

NCT03043261 is a NA study of Congestive Heart Failure that has completed, run by Duke University. The registered enrollment target is 3 participants, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03043261, a NA study of Congestive Heart Failure, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

EMERGE is a PI-initiated feasibility study that aims to evaluate the accessibility, usability, effectiveness and relevance of an integrated psycho-behavioral intervention on heart failure patients in order to increase support, outreach and general well-being of these patients following hospitalization due to heart failure exacerbation.

Conditions Studied

Interventions

  • BEHAVIORAL Williams LifeSkills

Study Locations (1)

North Carolina

  • Pamela Bonner - Durham

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2018-01-29
Est. Completion 2018-04-07
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03043261

The ClinicalTrials.gov registry entry for NCT03043261 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (99% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Williams LifeSkills is the first listed.

NCT03043261 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03043261 about?

NCT03043261 is a clinical study titled "Effective Management of Emotional Response to Generate Well-Being Post-HF Exacerbation". EMERGE is a PI-initiated feasibility study that aims to evaluate the accessibility, usability, effectiveness and relevance of an integrated psycho-behavioral intervention on heart failure patients in order to increase support, outreach and general well-being of these patients following hospitalizati...

What is the current status of trial NCT03043261?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2018-01-29. Estimated completion is 2018-04-07.

What conditions does trial NCT03043261 study?

This clinical trial studies the following conditions: Congestive Heart Failure.

What interventions are being tested in trial NCT03043261?

The interventions under investigation include: Williams LifeSkills (BEHAVIORAL).

Who is sponsoring clinical trial NCT03043261?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03043261 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congestive Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.